Combined valve replacement or valvulotomy and bypass graft surgery
Pierre Grondin, M.D.
P. Donzeau-Gouge, M.D.
O. Bical, M.D.
Jean Georges Kretz, M.D.
From 1969 to June 1977, 87 consecutive patients underwent simultaneous valve replacement or valvulotomy and aortocoronary bypass grafting at the Montreal Heart Institute. There were 64 men and 23 women (average age 56 years). Sixteen patients had no history of chest pains, but had severe functional incapacity. In all patients, significant coronary artery stenosis was demonstrated by cine coronary angiography.
Sixty-eight patients (78%) were considered functional Class II or III, and 62 patients (71%) experienced angina pectoris Class II or III. Aortic valve replacement was performed in 51 patients, mitral valve replacement was performed in 27, and 9 patients had both mitral and aortic valve replacement combined with coronary revascularization. Single aortocoronary bypass was performed in 65% of instances, double bypass was performed in 32%, and 3% had three or more arteries grafted.
To offer a greater margin of safety to these patients, we have used several technical variations with no significant difference in mortality or morbidity. In recent months, however, we have used cardioplegic solutions for myocardial protection in eight patients with no operative death and no perioperative myocardial infarction. We believe that this method of myocardial protection has much to offer in such combined operations to reduce the operative risk.
The global operative mortality was 18.3%: 15.6% in the aortic replacement group, 14.8% in the mitral replacement group, and 44.4% in the double valve replacement group. However, the late mortality was only 5.7% with an average follow-up of 44 months. The actuarial survival curve after 4 years was . . .